A mutation in plasma platelet-activating factor acetylhydrolase (Val279-->Phe) is a genetic risk factor for stroke.
about
The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthmaAssociation of a G994 -->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with risk of abdominal aortic aneurysm in JapaneseLipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complicationsPhospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic interventionAssociation of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population.Events at the vascular wall: the molecular basis of inflammation.Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2).Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes.Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2Lipoprotein-associated phospholipase A2: a novel marker of cardiovascular risk and potential therapeutic target.Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke.Associations of platelet-activating factor acetylhydrolase gene polymorphisms with risk of ischemic stroke.Lipoprotein-associated phospholipase A2: pathogenic mechanisms and clinical utility for predicting cardiovascular events.Influence of race and sex on lipoprotein-associated phospholipase A2 levels: observations from the Dallas Heart Study.Association of lipoprotein-associated phospholipase A2 with coronary calcification among American and Japanese menThe role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis.Lipoprotein-associated phospholipase A2 and risk of venous thrombosis in older adults.The prevalence of platelet activating factor acetylhydrolase single nucleotide polymorphisms in relationship to necrotizing enterocolitis in Northwest Louisiana infants.A phenome-wide association study of a lipoprotein-associated phospholipase A2 loss-of-function variant in 90 000 Chinese adults.Darapladib.Functional Consequences of Mutations and Polymorphisms in the Coding Region of the PAF Acetylhydrolase (PAF-AH) Gene.Receptor-dependent metabolism of platelet-activating factor in murine macrophages.Investigation of a Bicyclo[1.1.1]pentane as a Phenyl Replacement within an LpPLA2 Inhibitor.Inter-individual variability of plasma PAF-acetylhydrolase activity in ARDS patients and PAFAH genotype.Lipoprotein-associated phospholipase A2 gene V279F polymorphisms and coronary heart disease: a meta-analysis.The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity.Altered lipoprotein subclass distribution and PAF-AH activity in subjects with generalized aggressive periodontitis.Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenarians.Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo.Association of Lp-PLA2 G994T gene polymorphism with risk of ischemic stroke in Chinese population.Associations between four types of single-nucleotide polymorphisms in PLA2G7 gene and clinical atherosclerosis: a meta-analysis.
P2860
Q24540170-FD58F6E8-0E34-49AD-8564-5346CCB29536Q24542068-EADF90B8-1251-4C06-93A7-31FB444A1314Q26777871-05DB125F-3A07-4E6D-BF76-678B5AB7255CQ26997377-3F1C9A1C-1CD5-4D05-A5D8-96E5CF0189B5Q34037051-B8C04CD5-47AC-4654-B85B-57C94A7A626FQ34161044-F9A7AA5B-BC2D-49D9-A243-9B639396F7DFQ34864975-AA0F0742-F4E9-4E2B-B312-BC8B2C07AB94Q35621992-62BBB3FC-28DB-4A3B-B5A3-1A17F2362D09Q36024430-BCCE4BDC-2B32-4725-BD9E-54B13C222783Q36145180-459D95F8-7DC4-4990-AB56-C37F91D18CE5Q36187055-035C8F79-F448-42DE-ACB5-706EFBDC0B34Q36269180-0EFED60A-BB7B-477D-A614-E417FF1F4AFCQ36524201-252F0699-9C62-44C4-A0B8-EF9B1053CCEEQ36562248-27BDF5A6-3367-435A-A29B-BA3FAC11665FQ36808689-741B83CA-3756-4750-8635-EFDBDDCA2552Q36861883-DE0A8CF1-C8B1-4021-9507-C6642016A043Q36945209-6277E0E2-D72F-4D58-B791-3B4C55D88B8BQ37001368-5C452E0B-9A3E-4CDD-8CBE-404508CB023AQ37009251-3B6E9E0D-523C-4168-852D-AA8E707076E3Q37401167-38B11220-C985-4183-9004-173F1672A695Q37650398-FE2B53A1-E380-40F4-BB72-7D2F2CD91124Q37689865-E2BF2082-B9CB-4A71-A1F3-A07FC2A63EE8Q38293081-24747A64-B046-48F7-B715-97C6221D954BQ39011074-EA69FC57-64FE-44CE-9E83-7E2B31D5113FQ43800124-1D7CD4B2-5DDE-4908-B0F7-E265CA6069AEQ44071226-2A1A93CA-177D-45DF-8D9F-C3EE9093A693Q44516301-6712066C-3797-4E46-A11F-1917C735B927Q44913770-A92D7284-D7E9-4711-B026-4DB84336773BQ46631117-E0107B3F-F415-4650-BE18-C7365B8663AEQ46891942-0FFE31CB-B310-4DC1-B971-57670239507EQ48270915-F7B7F807-0BD5-4E89-A73B-6091EFE1CCD2Q49475562-538B6CAF-F9C1-4B39-80C0-638CF63052EC
P2860
A mutation in plasma platelet-activating factor acetylhydrolase (Val279-->Phe) is a genetic risk factor for stroke.
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
A mutation in plasma platelet- ...... enetic risk factor for stroke.
@ast
A mutation in plasma platelet- ...... enetic risk factor for stroke.
@en
A mutation in plasma platelet-activating factor acetylhydrolase
@nl
type
label
A mutation in plasma platelet- ...... enetic risk factor for stroke.
@ast
A mutation in plasma platelet- ...... enetic risk factor for stroke.
@en
A mutation in plasma platelet-activating factor acetylhydrolase
@nl
prefLabel
A mutation in plasma platelet- ...... enetic risk factor for stroke.
@ast
A mutation in plasma platelet- ...... enetic risk factor for stroke.
@en
A mutation in plasma platelet-activating factor acetylhydrolase
@nl
P2093
P1433
P1476
A mutation in plasma platelet- ...... enetic risk factor for stroke.
@en
P2093
P304
P356
10.1161/01.STR.28.12.2417
P407
P577
1997-12-01T00:00:00Z